INOmax® (nitric oxide) for inhalation
INOmax.com is your source for information about INOmax (nitric oxide) for inhalation.
INOmax (nitric oxide) for inhalation, in conjunction with ventilatory support and other appropriate agents, is indicated for the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure (HRF) associated with clinical or echocardiographic evidence of pulmonary hypertension, where it improves oxygenation and reduces the need for extracorporeal membrane oxygenation.

Important Safety Information

• INOmax should not be used in the treatment of neonates known to be dependent upon right-to-left shunting of blood
• Methemoglobinemia is a dose-dependent side effect of inhaled nitric oxide therapy. Therefore, methemoglobin levels should be monitored during INOmax administration. Caution should be used when administering INOmax with other drugs that may cause methemoglobinemia regardless of their route of administration
• Nitrogen dioxide (NO₂) forms rapidly in gas mixtures containing nitric oxide and oxygen. NO₂ formed in this way may cause airway inflammation and damage
• INOmax must be administered through a system which does not cause excessive generation of NO₂ and that monitors for NO, NO₂, and FiO₂
• Abrupt discontinuation of INOmax therapy may lead to worsening of PaO₂ and increasing pulmonary artery pressure (PAP). Deterioration in oxygenation and elevation in PAP may also occur in patients with no apparent response to INOmax
• 6-month follow-up data of patients in controlled studies who received INOmax (n=278)or placebo(n=212) found no evidence of an adverse event of treatment on the need for rehospitalization, special medical services, pulmonary disease, or neurologic sequelae

Adverse events from the CINRGI study with an incidence of at least 5% in patients receiving INOmax, and that were more common in INOmax patients compared with placebo patients.

INOmax [package insert]. Clinton, NJ: INO Therapeutics LLC; 2007

This site is intended for US medical audiences only. For non-US physicians, please click here.